Vandenbogaart Elizabeth, Doering Lynn, Chen Belinda, Saltzman Ann, Chaker Tamara, Creaser Julie W, Rourke Darlene, Cheng Richard W, Fonarow Gregg C, Deng Mario
Department of Medicine, Division of Cardiology, University of California Los Angeles, 100 Medical Plaza, Suite 630E, Los Angeles, CA, 90095, USA.
UCLA School of Nursing, 700 Tiverton Ave, Los Angeles, CA, 90095, USA.
Heart Lung. 2017 Jul-Aug;46(4):273-279. doi: 10.1016/j.hrtlng.2017.04.005. Epub 2017 May 17.
We evaluated the reliability of the Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) in heart transplant (HT) recipients and explored its usefulness in predicting post-transplant outcomes.
Pre-transplant psychosocial and behavioral risk is associated with post-transplant clinical outcomes. SIPAT is a risk assessment tool created for pre-transplant psychosocial evaluation.
Via retrospective chart review, three examiners applied the SIPAT to 51 adult HT recipients. Examiners blinded to SIPAT scores extracted data and interviewed clinicians for one-year post-transplant outcomes. Analysis included Intra-class correlation coefficient (ICC), Pearson's correlation coefficient and Chi-square.
SIPAT demonstrated strong inter-rater reliability (ICC = 0.89, 95% CI = 0.76-0.96). Compared to those with SIPAT ratings of "Excellent/Good", the "Minimally Acceptable Candidate/High Risk" group was more likely to miss clinic visits (p = 0.004).
The SIPAT tool had strong IRR. Less favorable SIPAT ratings were associated with nonadherence to clinic visits. Further study is warranted to determine association of SIPAT ratings to clinical outcomes.
我们评估了斯坦福移植综合心理社会评估(SIPAT)在心脏移植(HT)受者中的可靠性,并探讨了其在预测移植后结局方面的实用性。
移植前的心理社会和行为风险与移植后的临床结局相关。SIPAT是一种为移植前心理社会评估而创建的风险评估工具。
通过回顾性病历审查,三名检查者对51名成年HT受者应用了SIPAT。对SIPAT评分不知情的检查者提取数据,并就移植后一年的结局采访临床医生。分析包括组内相关系数(ICC)、皮尔逊相关系数和卡方检验。
SIPAT显示出较强的评分者间信度(ICC = 0.89,95%CI = 0.76 - 0.96)。与SIPAT评分为“优秀/良好”的患者相比,“勉强合格候选人/高风险”组更有可能错过门诊就诊(p = 0.004)。
SIPAT工具具有较强的评分者间信度。SIPAT评分较低与不遵守门诊就诊相关。有必要进行进一步研究以确定SIPAT评分与临床结局之间的关联。